Does Chemoimmunotherapy Still Have a Role in CLL? Chemoimmunotherapy With FCR Is Still an Important Option in CLL
Philip A Thompson, Constantine S Tam
Oncology (Williston Park, N.Y.) | UBM MEDICA | Published : 2018
Dr. Tam has received honoraria and research funding from AbbVie and Janssen. Dr. Thompson is an advisory board member and has received honoraria from Amgen, Genentech, and Pharmacyclics; he has also received honoraria from AbbVie.